AgingResearch.NewsJoin free

Reprogrammed CD8-positive t cells

Reprogrammed CD8-positive t cells has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 22, 2024: “Age-related features of lung cancer treatment using reprogrammed CD8 positive T cells in mice subjected to injection of Lewis lung carcinoma cells”.

Intervention

1 paper studies it1 findingUpdated

See all 1

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: Russian Academy of Sciences
  • Animals1

What did studies of Reprogrammed CD8-positive t cells find?

1

Studies of Reprogrammed CD8-positive t cells measured 1 outcome; the most studied are lung cancer (1 study).

Lung cancer

downin mice1

1 study

  1. Reprogrammed CD8-positive t cells decrease lung cancer in mice.

    “The antitumor effect of rCD8+ T cells in aged mice was found to be inferior to that in young mice”

    Animalsorthotopic Lewis lung carcinoma modelmales

    Age-related features of lung cancer treatment using reprogrammed CD8 positive T cells in mice subjected to injection of Lewis lung carcinoma cells

    Thoracic cancer

More on Lung cancer

Latest

Related